Otsuka And Lundbeck Begin To Reap Rewards Of Partnership
This article was originally published in The Pink Sheet Daily
Executive Summary
The Japanese company and its Danish partner garnered FDA approval for the long-acting injectable form of the blockbuster antipsychotic Abilify – the first approval of the five compounds the companies are partnered on.